Gastrectomy, Gastric Adenocarcinoma
Conditions
Brief summary
We conducted a retrospective study on patients with pathological stage II-III PGC who underwent PG or TG from 2013 to 2023. Propensity score-matching was applied to adjust for tumor size and stage between the PG and TG groups at a 1:1 ratio. We evaluated the procedural safety, oncological, and functional outcomes.
Interventions
PROCEDUREproximal gastrectomy
proximal gastrectomy
PROCEDUREtotal gastrectomy
total gastrectomy
Sponsors
National Taiwan University Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Proximal gastric adenocarcinoma after total or proximal gastrectomy.
Exclusion criteria
* Non-curative resections * Non-adenocarcinoma histology * Distally located tumors or middle/proximally located tumors for which distal margin could not be secured by PG * Remnant gastric cancer * Clinically T1N0 tumors smaller than 3 cm for which PG was clearly indicated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| five-year overall survival | 5 years |
Countries
Taiwan
Outcome results
None listed